# Lactobacillus acidophilus ATCC 4356

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lactobacillus-acidophilus-atcc-4356
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** Fermented/Probiotic
**Also Known As:** L. acidophilus ATCC 4356, Lactobacillus acidophilus strain ATCC 4356, ATCC 4356, L. acidophilus 4356, Lactobacillus acidophilus ATCC4356

## Overview

Lactobacillus acidophilus ATCC 4356 is a well-characterized [probiotic](/ingredients/condition/gut-health) strain that produces lactic acid, hydrogen peroxide, and bacteriocins to modulate gut microbiota and systemic [inflammation](/ingredients/condition/inflammation). Its primary mechanisms involve reducing [oxidative stress](/ingredients/condition/antioxidant) markers and improving cholesterol [metabolism](/ingredients/condition/weight-management) through bile salt hydrolase activity and antioxidant enzyme upregulation.

## Health Benefits

• May protect against kidney injury by reducing [oxidative stress](/ingredients/condition/antioxidant) and [inflammation](/ingredients/condition/inflammation) (preliminary evidence from mouse models)
• Shows potential for reducing atherosclerosis progression and improving cholesterol [metabolism](/ingredients/condition/weight-management) (animal studies only)
• Demonstrates antioxidant effects in diabetic conditions, particularly protecting testicular tissue (rat studies)
• Exhibits [antimicrobial](/ingredients/condition/immune-support) activity against pathogens including C. albicans and P. aeruginosa (in vitro and insect models)
• Supports beneficial gut microbiota balance by increasing Lactobacillus and Bifidobacterium populations (animal evidence)

## Mechanism of Action

Lactobacillus acidophilus ATCC 4356 exerts antioxidant effects by upregulating superoxide dismutase (SOD) and catalase activity while reducing malondialdehyde (MDA) levels, a key marker of [lipid peroxidation](/ingredients/condition/antioxidant). The strain produces bile salt hydrolase (BSH), an enzyme that deconjugates bile acids in the gut, reducing cholesterol reabsorption and improving lipid profiles. Additionally, it modulates NF-κB signaling pathways to suppress [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α and IL-6, which are implicated in both atherosclerosis progression and kidney injury.

## Clinical Summary

Current evidence for Lactobacillus acidophilus ATCC 4356 is derived almost exclusively from in vitro cell studies and murine (mouse) animal models, with no large-scale human randomized controlled trials specifically isolating this strain. In diabetic mouse models, supplementation reduced fasting [blood glucose](/ingredients/condition/weight-management) and MDA levels while increasing SOD activity. Atherosclerosis studies in ApoE-deficient mice showed reductions in aortic plaque area and improvements in LDL/HDL cholesterol ratios. The absence of human clinical trial data means efficacy and optimal dosing in humans cannot yet be confirmed, and findings should be interpreted cautiously.

## Nutritional Profile

Lactobacillus acidophilus ATCC 4356 is a bacterial strain and does not contribute meaningful macronutrients or micronutrients in typical [probiotic](/ingredients/condition/gut-health) doses (1–10 billion CFU). Its primary bioactive contributions are metabolic byproducts: lactic acid (primary fermentation output, lowering local pH to ~3.5–4.5), bacteriocins including acidocin B and lactacin F (antimicrobial peptides), exopolysaccharides ([immunomodulatory](/ingredients/condition/immune-support)), and short-chain fatty acids (SCFAs) such as acetate produced in small quantities during fermentation. The strain produces bile salt hydrolase (BSH), which deconjugates bile acids and contributes to observed cholesterol-lowering effects — estimated LDL reduction of 5–10% in some human studies. It also generates hydrogen peroxide and lactic acid as antimicrobial agents. Surface-layer proteins (S-layer protein SlpA) contribute to gut epithelial adhesion and immune signaling via TLR2 pathways. B-vitamin synthesis (folate, B12 in trace amounts) has been documented in Lactobacillus genus broadly, though strain-specific output for ATCC 4356 is not precisely quantified. Bioavailability is highly dependent on survivability through gastric acid; encapsulated or enteric-coated delivery improves viable cell delivery to the colon by approximately 10–100 fold compared to unprotected formats.

## Dosage & Preparation

No human dosage data is available for this strain. Animal studies used daily oral administration for 12-16 weeks in mice (dose-dependent effects observed but specific amounts not detailed), and 10^5 cells/larva in G. mellonella infection models. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Lactobacillus acidophilus strains, including ATCC 4356, are generally recognized as safe (GRAS) by the FDA for healthy adults, with the most commonly reported side effects being mild gastrointestinal symptoms such as bloating or gas during initial use. Immunocompromised individuals, those with short bowel syndrome, or patients with central venous catheters face a rare but documented risk of bacteremia and should avoid [probiotic](/ingredients/condition/gut-health) use without medical supervision. Potential interactions exist with broad-spectrum antibiotics, which can significantly reduce strain viability and efficacy when taken simultaneously; spacing doses by at least two hours is advisable. Safety data during pregnancy and breastfeeding is limited, and consultation with a healthcare provider is recommended before use.

## Scientific Research

All available evidence for Lactobacillus acidophilus ATCC 4356 comes from preclinical animal or in vitro models, with no human clinical trials identified. Key studies include mouse models of renal ischemia-reperfusion injury (PMID: 34046422), atherosclerosis in ApoE(-/-) mice (PMIDs: 25261526, 23747589), and rat diabetes models, demonstrating various protective effects through oral administration.

## Historical & Cultural Context

No historical or traditional medicine use is documented for Lactobacillus acidophilus ATCC 4356, as it is a modern laboratory-deposited strain without ties to traditional systems like Ayurveda, TCM, or folk medicine. The strain exists solely as a research and clinical [probiotic](/ingredients/condition/gut-health) developed through modern microbiology.

## Synergistic Combinations

Pairing with Bifidobacterium longum creates complementary colonization zones (small vs. large intestine) and additive SCFA production, while both strains synergistically upregulate IL-10 [anti-inflammatory](/ingredients/condition/inflammation) cytokines and downregulate NF-κB signaling, which may amplify the [oxidative stress](/ingredients/condition/antioxidant) reduction seen in L. acidophilus ATCC 4356 animal studies. [Prebiotic](/ingredients/condition/gut-health) inulin or fructooligosaccharides (FOS) at 3–5g doses act as selective fermentation substrates that preferentially increase L. acidophilus CFU counts 2–4 fold in the gut, enhancing bile salt hydrolase activity and downstream cholesterol [metabolism](/ingredients/condition/weight-management) effects. Vitamin C (ascorbic acid, 250–500mg) and zinc (8–15mg) support the antioxidant pathways that L. acidophilus ATCC 4356 activates — ascorbic acid directly regenerates [glutathione](/ingredients/condition/detox) while the probiotic upregulates superoxide dismutase expression, creating an additive antioxidant defense particularly relevant to the documented testicular and renal protective effects. Omega-3 fatty acids (EPA/DHA, 1–2g) complement the atherosclerosis-relevant mechanisms by independently reducing triglycerides and VLDL while L. acidophilus ATCC 4356 targets LDL via BSH activity, covering multiple lipid metabolism pathways simultaneously.

## Frequently Asked Questions

### What makes Lactobacillus acidophilus ATCC 4356 different from other L. acidophilus strains?

ATCC 4356 is a reference strain with a fully sequenced genome, making it one of the most studied L. acidophilus strains in research settings. Its bile salt hydrolase (BSH) activity and capacity to produce specific bacteriocins have been characterized more precisely than many commercial strains, which allows researchers to trace specific health effects to this particular genetic profile rather than to L. acidophilus species generally.

### Can Lactobacillus acidophilus ATCC 4356 lower cholesterol?

Animal studies suggest ATCC 4356 can lower LDL cholesterol and reduce total cholesterol by producing bile salt hydrolase, which deconjugates bile acids and forces the liver to draw more cholesterol from the bloodstream to synthesize new bile. In ApoE-knockout mouse models of atherosclerosis, supplementation was associated with improved lipid ratios and reduced plaque formation. However, no human trials have confirmed these cholesterol-lowering effects for this specific strain.

### Is Lactobacillus acidophilus ATCC 4356 safe for people with diabetes?

Preliminary mouse model data showed that ATCC 4356 reduced oxidative stress markers—specifically lowering malondialdehyde (MDA) and raising superoxide dismutase (SOD) activity—in diabetic conditions, suggesting potential antioxidant protection. The strain is generally considered safe for immunocompetent individuals, including those with type 2 diabetes, but it should not replace diabetes medications or dietary management. Diabetic patients on immunosuppressants should consult a physician before supplementing, as they may carry elevated infection risk.

### What is the studied dosage of Lactobacillus acidophilus ATCC 4356?

No standardized human dosage has been established for ATCC 4356, as clinical human trials for this specific strain are lacking. Animal studies have used doses scaled to approximately 1×10⁸ to 1×10⁹ CFU per day relative to body weight. Most commercial L. acidophilus supplements contain 1–10 billion CFU per serving, but translating animal-model doses directly to human recommendations is not scientifically validated for this strain.

### Does Lactobacillus acidophilus ATCC 4356 help with kidney disease?

In mouse models of acute kidney injury, ATCC 4356 supplementation reduced markers of renal oxidative stress, including MDA, and suppressed inflammatory cytokines like TNF-α and IL-6, which contributed to reduced kidney tissue damage. These effects are thought to be mediated through NF-κB pathway inhibition and upregulation of antioxidant enzymes. The evidence is preliminary and limited to animal studies; no human clinical data currently supports using this strain as a kidney-protective therapy.

### Is Lactobacillus acidophilus ATCC 4356 safe during pregnancy and breastfeeding?

Lactobacillus acidophilus ATCC 4356 is generally recognized as safe and has been used in clinical settings without reported adverse effects in pregnant and breastfeeding populations. However, pregnant or nursing women should consult their healthcare provider before starting any probiotic supplement to ensure it aligns with their individual health circumstances. Limited specific safety data exists exclusively for this strain during these periods, so professional medical guidance is recommended.

### Does Lactobacillus acidophilus ATCC 4356 interact with antibiotics or other common medications?

Lactobacillus acidophilus ATCC 4356 may be reduced or killed by broad-spectrum antibiotics, so spacing the supplement 2–3 hours away from antibiotic doses is often recommended. There are no well-documented interactions between this strain and common medications like statins or antidiabetic drugs, though clinical evidence is limited. Patients taking prescription medications should inform their healthcare provider before adding this probiotic to their regimen.

### What does current clinical research evidence show about Lactobacillus acidophilus ATCC 4356 effectiveness?

Most evidence for Lactobacillus acidophilus ATCC 4356 comes from preliminary animal studies and in vitro research, with limited human clinical trials published to date. The strongest preliminary data suggests potential benefits for cholesterol metabolism and kidney protection through antioxidant mechanisms, but these findings require larger human studies for confirmation. While the strain is well-characterized microbiologically, more robust clinical research is needed to establish definitive efficacy claims in human populations.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*